Both in Pharmaceuticals
Madrigal Pharmaceuticals vs Protagonist Therapeutics
Over the past year MDGL returned −2.6% and PTGX returned +87.2%; their daily moves had a correlation of 0.27.
MDGL −2.6% PTGX +87.2%Growth of $1, one year, split-adjusted
| Metric | MDGL | PTGX |
|---|---|---|
| Price | $401.70 | $142.15 |
| Market cap | $9.28B | $9.20B |
| Today | −6.83% | +1.99% |
| 1 month | −18.6% | +1.1% |
| 6 months | −20.1% | +43.3% |
| Year to date | −31.0% | +62.7% |
| 1 year | −4.1% | +80.8% |
| Revenue growth (YoY) | +71.2% | +3749.2% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −15.9% | 76.3% |
| P/E (TTM) | — | 110.9× |
| Price / sales | 7.2× | 32.6× |
| Net cash | $498.0M | $782.6M |
| Dividend yield | — | — |
| Volatility (60d) | 33.9% | 32.0% |
| Short % of float | 14.7% | 16.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).